| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5603688 | IJC Metabolic & Endocrine | 2017 | 7 Pages |
Abstract
These findings suggest that serum LDL-C reduction by ezetimibe might be associated with the improvement of postprandial hyperlipidemia in diabetic patients with CAD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Akihiro Nakamura, Shoko Kajitani, Yuto Monma, Kenjiro Sato, Yosuke Terui, Masanori Kanazawa, Kazuki Noda, Hideaki Endo, Tohru Takahashi, Eiji Nozaki,